weight
Cancer Risk Reduction and GLP-1 Medications
Obesity is linked to 13 types of cancer. Weight loss from GLP-1s may reduce cancer risk, though direct cancer prevention data is still emerging.
13
Cancer types linked to obesity
Significant
Risk reduction with weight loss
Emerging
Direct GLP-1 data
Weight Loss and Cancer
Obesity increases risk of breast, colon, endometrial, kidney, liver, and other cancers through inflammation and hormonal changes. Weight loss of 10-15% reduces cancer risk. GLP-1-induced weight loss may reduce obesity-related cancer risk. Direct cancer prevention studies are ongoing. Improved metabolic health reduces cancer-promoting inflammation.
Screening
Maintain age-appropriate cancer screening during weight loss. Weight loss may make some screenings easier (mammography). Discuss family history with your provider. SeraVia formulations support overall health.
Medications commonly used
Find providers who understand cancer risk reduction
Compare GLP-1 providers by clinical oversight, medication options, pricing, and local availability.
Related conditions